SCHEMBL6739168

SCHEMBL6739168

Cc1ccccc1C(=O)OC1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 3/20 0.51
▸ LGALS9 O00182 2/20 0.51
▸ LGALS1 P09382 2/20 0.51
▸ LGALS7; LGALS7B P47929 2/20 0.51
▸ SLC5A2 P31639 5/20 0.47
▸ SLC28A3 Q9HAS3 2/20 0.47
▸ LGALS4 P56470 1/20 0.46
▸ SLC5A1 P13866 3/20 0.46
▸ EPHX2 P34913 1/20 0.45
▸ LGALS8 O00214 1/20 0.45
▸ MAOB P27338 1/20 0.43
▸ SYNJ2 O15056 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ ALPL P05186 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALPI P09923 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALPG P10696 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29278300 1.00 LGALS3 (0.51) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
Hydrochloric Acid SCHEMBL28792398 0.99 LGALS3 (0.50) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL8148480 0.90 LGALS3 (0.52) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL4652290 0.84 SLC28A3 (0.55) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL30441333 0.84 LGALS9 (0.48) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL5827543 0.82 SIRT3 (0.41) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL11412734 0.81 SLC28A3 (0.53) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC5A2
SCHEMBL7141014 0.80 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC28A3
SCHEMBL7144990 0.80 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC28A3
SCHEMBL6570199 0.80 LGALS9 (0.61) LGALS3LGALS9LGALS1LGALS7; LGALS7BSLC28A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38416-E1 NUCLEOTIDE BASES COMPRISING PYRAZOLO(3,4-D)PYRIMIDINES USED FOR MEDICAL DIAGNOSIS, THERAPY, HYBRIDIZATION, ANTISENSE AGENTS OR REPORTER MOLECULES EPOCH BIOSCIENCES, INC. 2004-02-03 — — US disclosed
Send feedback